StockWatch
·
 Medicinal Chemicals and Botanical Products
Quarterly ResultOct 21, 2026, 07:11 AM

Philip Morris International Q3 Adjusted EPS Up 5.4% to $2.36; Raises FY26 Forecast

AI Summary

Philip Morris International Inc. announced its third-quarter 2026 financial results, reporting a 5.4% year-over-year increase in Adjusted Diluted EPS to $2.36 and a 5.5% rise in net revenues to $11.4 billion. The company also updated its full-year 2026 Adjusted Diluted EPS forecast to a range of $8.29 to $8.44, indicating projected growth of 9.9% to 11.9% excluding currency. Growth was driven by strong performance in both smoke-free and combustible product segments, with notable increases in shipment volumes for smoke-free products and robust pricing in the combustibles segment. The U.S. segment also saw significant revenue growth, primarily from ZYN shipments.

Key Highlights

  • Philip Morris International reported Q3 2026 Adjusted Diluted EPS of $2.36, a 5.4% increase YoY.
  • Q3 2026 Net revenues increased by 5.5% to $11.4 billion, with organic growth of 7.1%.
  • Q3 2026 Reported Diluted EPS declined by 4.9% to $2.12, mainly due to non-cash fair value adjustments.
  • Smoke-free products (SFP) shipment volume increased by 2.7% in Q3 2026.
  • International Combustibles segment net revenues grew by 6.5% organically, driven by 8.9% pricing.
  • U.S. Segment net revenues grew by 22.7% organically, driven by ZYN shipments and favorable pricing.
  • PMI updated its 2026 full-year Adjusted Diluted EPS forecast to a range of $8.29 to $8.44, representing 9.9% to 11.9% growth excluding currency.